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CLINICAL RECOGNITION OF SYMPTOMATIC MIDFOOT
OSTEOARTHRITIS: FINDINGS FROM THE CLINICAL ASSESSMENT
STUDY OF THE FOOT
M.J. Thomas y, E. Roddy y, T. Rathod y, A. Moore y, H.B. Menz y,z,
G. Peat y. yKeele Univ., Staffordshire, United Kingdom; z La Trobe Univ.,
Melbourne, Australia
Purpose: Osteoarthritis (OA) is a common yet poorly understood cause
of disabling foot pain. In the absence of radiographic conﬁrmation of
OA, clinical diagnosis in primary care is inhibited by lack of evidence
informing clinical examination. This study aimed to determine whether
the presence of symptomatic midfoot OA (SMOA) can be clinically
identiﬁed in older adults with midfoot pain presenting to primary care.
Methods: A diagnostic model using brief clinical assessments was
developed using cross-sectional data from 274 adults aged 50 years
who had self-reported midfoot pain in the last month and attended a
research assessment clinic between 2010-2011. All clinical assessment
data were collected by trained physiotherapy or podiatry assessors
adhering to a standardised, quality-controlled protocol. Presence of
radiographic midfoot OA in at least one of four scored joints (1st and
2nd cuneo-metatarsal joint, navicular-ﬁrst cuneiform joint, and talo-
navicular joint) was ascertained by a single reader using a validated
atlas and scoring system, and who was blinded to the clinical assess-
ment data. Radiographic OA was deﬁned as a score of 2 for osteo-
phytes or joint space narrowing on either weight-bearing dorso-plantar
or lateral views. SMOAwas deﬁned as co-occuring radiographic OA and
midfoot pain. One foot per participant was entered into the analysis.
The selection of predictor variables was based on known associations
with OA or mechanically-driven putative links to SMOA. Signiﬁcant
predictor variables (p<0.25 from likelihood ratio tests) from univariable
analyses were simultaneously entered into a multivariable logistic
regression model and backward elimination (p¼0.05) was performed.
The Hosmer-Lemeshow statistic assessed the calibration of the reﬁtted
model and the area under the curve (AUC) evaluated discrimination.
Histograms visually summarised discrimination. Internal validation of
the model was performed using 1000 bias-corrected bootstrap samples
with replacement.
Results: 274 participants without inﬂammatory disease comprised 125
men and 149 women (mean age 65 yrs, SD 9). Of these 155 had midfoot
pain and 119 had SMOA. 16 univariable analyses identiﬁed 9 signiﬁcant
predictors and no collinearity was observed. In addition to force-
entered variables (age, gender, body mass index (BMI)), only two
independent predictors of SMOA were retained in the multivariable
analysis: (i) reduced ankle dorsiﬂexion with the knee ﬂexed and (ii)
absence of a midfoot exostosis. Based on the strength of univariable
association, the Foot Posture Index, subtalar inversion and ankle dor-
siﬂexionwith the knee extended appeared tooweak to contribute to the
ﬁnal model, whereas the removal of the Arch Index and foot length-
corrected navicular height was due to the stronger inﬂuence of age
explaining these relationships. The ﬁnal ﬁtted model was well cali-
brated (p¼0.79) but discrimination was poor (AUC, 0.69; 95%CI: 0.62,
0.75). Bootstrapping revealed a small degree of overﬁtting. The use of
categorical predictor variables in continuous form did not identify any
other predictors, nor did it improve model performance.
Conclusions: Brief clinical assessments offer only marginal improve-
ment to age, gender and BMI for identifying SMOA. Milder severity in aTable: Associations between baseline MRI sum scores and changes of pain and physi
AUSCAN pain
Descriptives
Mean (SD) at baseline 8.0 (3.9)
Median (IQR) change 0 (-2, 2)
n (%) above PASS (baseline) 39 (56%)
n (%) above PASS (follow-up) 37 (53%)
Associations between MRI sum scores and changes in pain and physical function, B (9
Synovitis 0.01 (-0.29, 0.32)
Bone marrow lesions -0.26 (-0.55, 0.03)
Central erosions -0.38 (-0.71, -0.04)
Associations between MRI sum scores and symptoms above PASS, Odds ratio (95% CI)
Synovitis 1.03 (0.85, 1.24)
Bone marrow lesions 0.92 (0.78, 1.08)
Central erosions 0.95 (0.79, 1.14)
PASS¼patient acceptable symptom statepopulation sample, random and systematic error in the clinical
assessment, and variable expression of SMOA disease manifestation
may have contributed to poor diagnostic accuracy. A clinically deﬁned
SMOA phenotype based on modiﬁable joint loading characteristics may
offer an alternative approach to facilitating the development of more
targeted biomechanical interventions.
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PREDICTIVE VALUE OF MRI-DEFINED SYNOVITIS, BONE MARROW
LESIONS AND CENTRAL EROSIONS ON PAIN AND PHYSICAL
FUNCTION IN HAND OSTEOARTHRITIS
I.K. Haugen, I. Karlsen Eeg, B. Slatkowsky-Christensen, S. Sesseng,
T.K. Kvien. Diakonhjemmet Hosp., Oslo, Norway
Purpose: A previous study in hand osteoarthritis (OA) suggested that
Magnetic Resonance Imaging (MRI)-deﬁned synovitis, bone marrow
lesions (BML) and central erosions (bone attrition) are associated with
pain upon palpation. The predictive value of these MRI features is
unknown due to lack of longitudinal hand OA studies, in which MRI is
obtained. Hence, our aim was to examine whether synovitis, BMLs and
central erosions can predict clinical deterioration and poor clinical
outcome 5 years later in patients with hand OA.
Methods:We included 70 (63 women) participants from the Oslo hand
OA cohort with mean (SD) age of 67.9 (5.3) years and BMI of 26.4 (3.8)
kg/m2.). At baseline (2008-09) and follow-up (2013), all participants
completed the Australian/Canadian (AUSCAN) pain (0-20 scale) and
physical function subscales (0-36 scale, higher scores represent worse
health) and 59 participants underwent grip strength measurement of
the dominant hand (Jamar dynamometer). MRIs of the distal and
proximal interphalangeal joints in the dominant hand were obtained at
baseline. MRI sequences included T1-weighted pre-and post-Gadolo-
nium (Gd) images in coronal, axial and sagittal planes and Short Tau
Inversion Recovery images in coronal and axial planes (n¼9 without Gd
contrast). One reader (IKH) scored the MRIs according to the Oslo hand
OA MRI score, and we calculated sum scores for synovitis (range 0-24),
BMLs (range 0-48) and central erosions (range 0-16). The associations
between MRI sum scores and change of AUSCAN subscales and grip
strength were examined by linear regression analyses. We also exam-
ined the associations betweenMRI sum scores and symptoms above the
patient acceptable symptom state (PASS) (>8.2 for AUSCAN pain and
>16.1 for AUSCAN physical function) at follow-up with logistic regres-
sion analyses. All analyses were adjusted for age, sex, BMI and follow-up
time.
Results: At baseline the participants reported considerable pain and
physical disability (Table). Synovitis was frequently present, whereas
BMLs and central erosions were less common. The median (range) for
sum scores were 8 (0-14), 0.5 (0-14) and 1 (0-12), respectively. During
follow-up (mean (SD) 4.7 (0.3) years), there were small changes of
AUSCAN pain, physical function and grip strength (Table). We found
that MRI ﬁndings in the interphalangeal joints could not predict
changes in pain and physical function or future symptoms above the
PASS score (Table).
Conclusions: In a cohort of patients with established hand OA, we
observed small changes in symptoms and grip strength over a 5-year
period. MRI-determined synovitis, BMLs and central erosions could not
predict symptom changes or future poor clinical outcome. Futurecal function.
AUSCAN physical function Grip strength
15.4 (7.9) 21.2 (8.2)
0 (-2, 3) -2 (-5, 1)
31 (44%) NA
34 (49%) NA
5% CI)
0.004 (-0.40, 0.41) -0.06 (-0.47, 0.34)
0.01 (-0.34, 0.36) 0.05 (-0.35, 0.46)
-0.05 (-0.46, 0.36) 0.58 (0.12, 1.04)
1.14 (0.94, 1.37) NA
0.96 (0.82, 1.12) NA
0.99 (0.82, 1.20) NA
